Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030263 · ClinicalTrials.gov registry record · Phase 4
A Trial Comparing Yield of Confocal Endomicroscopy Guided Biopsies
A Phase 4 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT01030263: Clinical Trial Phase 4 study, sponsored by Mayo Clinic.
NCT01030263 is a Phase 4 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01030263, a Phase 4 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
We wish to determine whether biopsies obtained with the technique of fluorescence-aided confocal endomicroscopy will detect more patients with specialized columnar epithelium than random biopsies among patients with Barrett's esophagus who are being monitored with endoscopy.
Interventions
- OTHER Fluorescence-aided confocal endomicroscopy guided biopsy.
- OTHER Random four-quadrant biopsies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01030263
The ClinicalTrials.gov registry entry for NCT01030263 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluorescence-aided confocal endomicroscopy guided biopsy. is the first listed.
NCT01030263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01030263 about?
NCT01030263 is a clinical study titled "A Trial Comparing Yield of Confocal Endomicroscopy Guided Biopsies". We wish to determine whether biopsies obtained with the technique of fluorescence-aided confocal endomicroscopy will detect more patients with specialized columnar epithelium than random biopsies among patients with Barrett's esophagus who are being monitored with endoscopy.
What is the current status of trial NCT01030263?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2008-06. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01030263?
The interventions under investigation include: Fluorescence-aided confocal endomicroscopy guided biopsy. (OTHER), Random four-quadrant biopsies. (OTHER).
Who is sponsoring clinical trial NCT01030263?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.